DURHAM,
N.C. and BEIJING,
May 24,
2022 /PRNewswire/ -- Brii
Biosciences Limited ("Brii Bio"
or the "Company", stock code: 2137.HK) today announced that it will
be added to the MSCI China Small Cap Index, effective as of
Hong Kong market close on
May 31, 2022.
The MSCI China Small Cap Index is an equity index compiled by
MSCI Inc., a leading provider of critical decision support tools
and services for the global investment community. The index is
designed to measure the performance of the China market's small-cap segment and is widely
recognized by the international financial community, as a benchmark
for global institutional investors seeking to optimize their
investment portfolios. Brii Bio was
selected to be included in this index following its May 2022 Semi-Annual Index Review for the MSCI
Equity Indexes.
Dr. Ankang Li, Chief Financial and Strategy Officer of Brii
Biosciences, commented, "Becoming a constituent of the MSCI China
Small Cap Index is another significant capital markets milestone
for Brii Bio, following our
inclusion in the Hang Seng Composite Index and the Shenzhen-Hong
Kong Stock Connect last year. Being among the few biotech stocks
included in one of the most influential China-focused indexes in the global capital
markets demonstrates our growing visibility and recognition by the
global investor community. We look forward to continuing to deliver
shareholder value by developing innovative therapies for diseases
around the world with significant unmet medical needs and large
public health burdens."
About Brii Bio
Brii Biosciences Limited ("Brii
Bio," stock code: 2137.HK) is a biotechnology company based
in China and the United States committed to advancing
therapies for significant infectious diseases, such as hepatitis B,
COVID-19, human immunodeficiency virus (HIV) infection, multi-drug
resistant (MDR) or extensive drug resistant (XDR) gram-negative
infections, and other illnesses, such as the central nervous system
(CNS) diseases, which have significant public health burdens in
China and worldwide. For more
information, visit www.briibio.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/brii-biosciences-to-be-added-to-msci-china-small-cap-index-301553971.html
SOURCE Brii Biosciences Limited